SuperworthPTC Therapeutics market cap PTCT
Share price times shares outstanding: what the whole company sells for, since 2013.
- Today, Oct 23, 2026
- $5.1B
- Highest close in our data
- $6.9B
- Nov 2025
PTC Therapeutics is worth $5.1B at the close on Oct 23, 2026, at $60.59 a share.
That is down 4% over the last year and up 89% over five years.
Its highest close in our data was $6.9B in Nov 2025.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $5.1B | $570.8M | $6.2B | −20% |
| 2025 | $6.3B | $3.4B | $6.9B | +81% |
| 2024 | $3.5B | $1.9B | $3.7B | +68% |
| 2023 | $2.1B | $1.4B | $4.3B | −24% |
| 2022 | $2.7B | $1.9B | $3.8B | −3% |
| 2021 | $2.8B | $2.5B | $4.7B | −32% |
| 2020 | $4.2B | $2.5B | $4.6B | +38% |
| 2019 | $3B | $1.5B | $3B | +86% |
| 2018 | $1.6B | $743.9M | $2.2B | +133% |
| 2017 | $692M | $294.4M | $884.3M | +85% |
| 2016 | $374.4M | $171.6M | $988.4M | −66% |
| 2015 | $1.1B | $852.3M | $2.5B | −38% |
| 2014 | $1.8B | $434.8M | $1.9B | +304% |
| 2013 | $443.5M | $362.8M | $532.5M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest PTC Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| PTCTPTC Therapeutics | $5.1B |
| KNSAKiniksa Pharmaceuticals International | $6B |
| LGNDLigand Pharmaceuticals | $6.1B |
| INDVIndivior Pharmaceuticals | $4.1B |
| AMRXAmneal Pharmaceuticals | $6.5B |
| ARQTArcutis Biotherapeutics | $3.9B |
| LQDALiquidia | $3.8B |
| OGNOrganon | $3.6B |
| ALKSAlkermes plc. | $7.3B |
| TGTXTG Therapeutics | $8.3B |
| PTGXProtagonist Therapeutics | $9B |
| Peer median | $6B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on PTC Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.